152 related articles for article (PubMed ID: 34305410)
1. The Biological Function of TUSC7/miR-1224-3p Axis in Triple-Negative Breast Cancer.
Zheng BH; He ZX; Zhang J; Ma JJ; Zhang HW; Zhu W; Shao ZM; Ni XJ
Cancer Manag Res; 2021; 13():5763-5774. PubMed ID: 34305410
[TBL] [Abstract][Full Text] [Related]
2. The Novel Long Noncoding RNA TUSC7 Inhibits Proliferation by Sponging MiR-211 in Colorectal Cancer.
Xu J; Zhang R; Zhao J
Cell Physiol Biochem; 2017; 41(2):635-644. PubMed ID: 28214867
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of long noncoding RNA TUSC7 promoted cell growth, invasion and migration through sponging with miR-616-5p/GSK3β pathway in ovarian cancer.
Zhu LM; Li N
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7253-7265. PubMed ID: 32706063
[TBL] [Abstract][Full Text] [Related]
4. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.
Chen H; Pan H; Qian Y; Zhou W; Liu X
Mol Cancer; 2018 Jan; 17(1):4. PubMed ID: 29310680
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X
Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA TUSC7 inhibits cell proliferation, migration and invasion by regulating SOCS4 (SOCS5) expression through targeting miR-616 in endometrial carcinoma.
Wu X; Cai D; Zhang F; Li M; Wan Q
Life Sci; 2019 Aug; 231():116549. PubMed ID: 31200002
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway.
Wang X; Chen T; Zhang Y; Zhang N; Li C; Li Y; Liu Y; Zhang H; Zhao W; Chen B; Wang L; Yang Q
J Cell Physiol; 2019 Aug; 234(8):13303-13317. PubMed ID: 30618083
[TBL] [Abstract][Full Text] [Related]
8. Effects of lncRNA TUSC7 on the malignant biological behavior of osteosarcoma cells via regulation of miR-375.
Wang L; Jiang J; Sun G; Zhang P; Li Y
Oncol Lett; 2020 Nov; 20(5):133. PubMed ID: 32934702
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA MIR100HG promotes the migration, invasion and proliferation of triple-negative breast cancer cells by targeting the miR-5590-3p/OTX1 axis.
Chen FY; Zhou ZY; Zhang KJ; Pang J; Wang SM
Cancer Cell Int; 2020; 20():508. PubMed ID: 33088216
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA TUSC7 suppresses osteosarcoma by targeting miR-211.
Cong M; Jing R
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31652435
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
[TBL] [Abstract][Full Text] [Related]
12. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
[TBL] [Abstract][Full Text] [Related]
14. The miR-124-3p/Neuropilin-1 Axis Contributes to the Proliferation and Metastasis of Triple-Negative Breast Cancer Cells and Co-Activates the TGF-β Pathway.
Zhang J; Zhang X; Li Z; Wang Q; Shi Y; Jiang X; Sun X
Front Oncol; 2021; 11():654672. PubMed ID: 33912463
[TBL] [Abstract][Full Text] [Related]
15. miR-143-3p targeting LIM domain kinase 1 suppresses the progression of triple-negative breast cancer cells.
Li D; Hu J; Song H; Xu H; Wu C; Zhao B; Xie D; Wu T; Zhao J; Fang L
Am J Transl Res; 2017; 9(5):2276-2285. PubMed ID: 28559978
[TBL] [Abstract][Full Text] [Related]
16. lncRNA TUSC7 inhibits osteosarcoma progression through the miR‑181a/RASSF6 axis.
Zhao A; Liu W; Cui X; Wang N; Wang Y; Sun L; Xue H; Wu L; Cui S; Yang Y; Bai R
Int J Mol Med; 2021 Feb; 47(2):583-594. PubMed ID: 33416181
[TBL] [Abstract][Full Text] [Related]
17. LINC01096 knockdown inhibits progression of triple-negative breast cancer by increasing miR-3130-3p.
Wang GP; Mou ZL; Xu YY; Liu GX; Wang DM; Zhang HP
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7445-7456. PubMed ID: 31539132
[TBL] [Abstract][Full Text] [Related]
18. Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT/mTOR pathway.
Liu M; Yang J; Lv W; Wang S; Du T; Zhang K; Wu Y; Feng X
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34935899
[TBL] [Abstract][Full Text] [Related]
19. LncRNA-HAGLR motivates triple negative breast cancer progression by regulation of WNT2 via sponging miR-335-3p.
Jin L; Luo C; Wu X; Li M; Wu S; Feng Y
Aging (Albany NY); 2021 Aug; 13(15):19306-19316. PubMed ID: 34375306
[TBL] [Abstract][Full Text] [Related]
20. MiR-193 promotes cell proliferation and invasion by ING5/PI3K/AKT pathway of triple-negative breast cancer.
Xu JH; Zhao JX; Jiang MY; Yang LP; Sun ML; Wang HW
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3122-3129. PubMed ID: 32271430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
